Positive effect of septimeb™ on mortality rate in severe sepsis: a novel non antibiotic strategy
Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0
Abstract
Background Septimeb is a new herbal-derived remedy, recently approved for its potential immunomodulatory effects. Regarding the key role of immune system in the pathogenesis of severe sepsis and lack of any standard treatment for improving survival of these patients; we evaluated the effect of Septimeb -as an adjutant to standard treatment-on inflammatory biomarkers and mortality rates in patients with severe sepsis. Methods In this multicenter, randomized, single-blind trial, we assigned patients with severe sepsis and Acute Physiology and Chronic Health Evaluation (APACHE II) score of more than 20 to receive standard treatment of severe sepsis (control group) or standard treatment plus Septimeb. This group was treated with Septimeb for 14 days then followed up for another14 days. APACHE score, Sequential Organ Failure Assessment (SOFA) and Simplified Acute Physiology Score (SAPS) were calculated daily. Blood samples were analyzed for interleukin 2 tumor necrosis factor-α, total antioxidant power, platelet growth factor and matrix metalloproteinase 2. Results A total of 29 patients underwent randomization (13 in control group and 16 in Septimeb group). There was significant difference between the Septimeb and control group in the 14 days mortality rate (18.8% vs. 53.85 respectively, P=0.048). Compared to control group, Septimeb was significantly effective in improving SAPS (P= 0.029), SOFA (P=0.003) and APACHE II (P=0.008) scores. Inflammatory biomarkers didn’t change significantly between the two groups (P>0.05). Conclusion Septimeb reduces mortality rates among patients with severe sepsis and it could be added as a safe adjutant to standard treatment of sepsis.
Authors and Affiliations
Kaveh Eslami, Ata Mahmoodpoor, Arezoo Ahmadi, Mohammad Abdollahi, Koorosh Kamali, Sarah Mousavi, Atabak Najafi, Maryam Baeeri, Hadi Hamishehkar, Leila Kouti, Mohammad Reza Javadi, Mojtaba Mojtahedzadeh
Keywords
Related Articles
- EP ID EP135403
- DOI -
- Views 111
- Downloads 0
An efficient piecewise linear model for predicting activity of caspase-3 inhibitors
Background and purpose of the study Multimodal distribution of descriptors makes it more difficult to fit a single global model to model the entire data set in quantitative structure activity relationship (QSAR) studies....
A review on delayed toxic effects of sulfur mustard in Iranian veterans
Iranian soldiers were attacked with chemical bombs, rockets and artillery shells 387 times during the 8-years war by Iraq (1980--1988). More than 1,000 tons of sulfur mustard gas was used in the battlefields by the Iraqi...
Monitoring of adverse drug reactions associated with antihypertensive medicines at a university teaching hospital in New Delhi
Aim To monitor the adverse drug reactions (ADRs) caused by antihypertensive medicines prescribed in a university teaching hospital.Methods The present work was an open, non-comparative, observational study conducted on...
Reporting of adverse drug reactions: An exploratory study among nurses in a teaching hospital, Ajman United Arab Emirates
Background and the purpose of the study Adverse drug reactions (ADRs) are important public health problem with significant morbidity, mortality and financial burden on the society. Nurses play important role in medicatio...
In vitro and in vivo activities of ticarcillin-loaded nanoliposomes with different surface charges against pseudomonas aeruginosa (ATCC 29248)
Pseudomonas aeruginosa exhibits multiple antibiotic resistance mechanisms. Different studies have shown that entrapment of antibiotics into liposomes could increase their anti- Pseudomonas activity. The objectives of thi...